Highlander Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $48.4K | Sell |
500
-150
| -23% | -$15.4K | 0.02% | 396 |
|
|
2023
Q4 | $65.6K | Hold |
650
| – | – | 0.02% | 349 |
|
|
2023
Q3 | $66K | Buy |
650
+500
| +333% | +$50.8K | 0.03% | 338 |
|
|
2023
Q2 | $15K | Hold |
150
| – | – | 0.01% | 478 |
|
|
2023
Q1 | $14K | Hold |
150
| – | – | 0.01% | 476 |
|
|
2022
Q4 | $14K | Hold |
150
| – | – | 0.01% | 447 |
|
|
2022
Q3 | $11K | Hold |
150
| – | – | 0.01% | 452 |
|
|
2022
Q2 | $13K | Hold |
150
| – | – | 0.01% | 447 |
|
|
2022
Q1 | $13K | Hold |
150
| – | – | 0.01% | 452 |
|
|
2021
Q4 | $13K | Hold |
150
| – | – | 0.01% | 446 |
|
|
2021
Q3 | $12K | Hold |
150
| – | – | 0.01% | 443 |
|
|
2021
Q2 | $14K | Hold |
150
| – | – | 0.01% | 442 |
|
|
2021
Q1 | $13K | Hold |
150
| – | – | 0.01% | 457 |
|
|
2020
Q4 | $14K | Hold |
150
| – | – | 0.01% | 453 |
|
|
2020
Q3 | $13K | Hold |
150
| – | – | 0.01% | 456 |
|
|
2020
Q2 | $13K | Hold |
150
| – | – | 0.01% | 457 |
|
|
2020
Q1 | $12K | Hold |
150
| – | – | 0.01% | 464 |
|
|
2019
Q4 | $14K | Hold |
150
| – | – | 0.01% | 477 |
|
|
2019
Q3 | $13K | Hold |
150
| – | – | 0.01% | 502 |
|
|
2019
Q2 | $14K | Sell |
150
-17
| -10% | -$1.44K | 0.01% | 518 |
|
|
2019
Q1 | $14K | Sell |
167
-489
| -75% | -$39.3K | 0.01% | 520 |
|
|
2018
Q4 | $50K | Hold |
656
| – | – | 0.03% | 309 |
|
|
2018
Q3 | $51K | Hold |
656
| – | – | 0.03% | 349 |
|
|
2018
Q2 | $44K | Hold |
656
| – | – | 0.02% | 374 |
|
|
2018
Q1 | $47K | Hold |
656
| – | – | 0.03% | 363 |
|
|
2017
Q4 | $49K | Hold |
656
| – | – | 0.04% | 357 |
|
|
2017
Q3 | $50K | Hold |
656
| – | – | 0.04% | 351 |
|
|
2017
Q2 | $49K | Hold |
656
| – | – | 0.04% | 353 |
|
|
2017
Q1 | $44K | Hold |
656
| – | – | 0.04% | 365 |
|
|
2016
Q4 | $43K | Hold |
656
| – | – | 0.04% | 370 |
|
|
2016
Q3 | $46K | Hold |
656
| – | – | 0.04% | 368 |
|
|
2016
Q2 | $49K | Hold |
656
| – | – | 0.04% | 355 |
|
|
2016
Q1 | $43K | Hold |
656
| – | – | 0.04% | 385 |
|
|
2015
Q4 | $51K | Hold |
656
| – | – | 0.05% | 353 |
|
|
2015
Q3 | $54K | Hold |
656
| – | – | 0.05% | 342 |
|
|
2015
Q2 | $58K | Hold |
656
| – | – | 0.05% | 340 |
|
|
2015
Q1 | $58K | Hold |
656
| – | – | 0.05% | 345 |
|
|
2014
Q4 | $54K | Hold |
656
| – | – | 0.05% | 359 |
|
|
2014
Q3 | $55.3K | Hold |
656
| – | – | 0.05% | 323 |
|
|
2014
Q2 | $53.2K | Hold |
656
| – | – | 0.05% | 334 |
|
|
2014
Q1 | $50K | Hold |
656
| – | – | 0.05% | 350 |
|
|
2013
Q4 | $47.3K | Hold |
656
| – | – | 0.04% | 352 |
|
|
2013
Q3 | $45.1K | Hold |
656
| – | – | 0.05% | 360 |
|
|
2013
Q2 | $41.6K | Buy |
+656
| New | +$42.7K | 0.04% | 374 |
|
Other funds holding NVS
Highlander Capital Management's NVS Position: Q1 2024 in Review
Highlander Capital Management reduced its Novartis (NVS) stake by 23% in Q1 2024, selling an estimated $15.4K and leaving 500 shares worth $48.4K. The position accounts for 0.02% of the portfolio, ranked #396.
Highlander Capital Management first reported a position in NVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $66K in Q3 2023. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.
- Highlander Capital Management held 500 shares of Novartis worth $48.4K as of Q1 2024.
- Highlander Capital Management sold 150 Novartis shares in Q1 2024, an estimated $15.4K.
- Novartis made up 0.02% of Highlander Capital Management's portfolio in Q1 2024, its #396 holding.
- Highlander Capital Management first reported a position in Novartis in Q2 2013 and has held it in 44 quarters since.
- Highlander Capital Management's Novartis position peaked at $66K in Q3 2023.
- 1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.